FutureChem Co.,Ltd (KOSDAQ:220100)
South Korea · Delayed Price · Currency is KRW 21,100
+100 (0.48%)
At close: Mar 20, 2026
FutureChem Co.,Ltd Revenue
In the year 2025, FutureChem Co.,Ltd had annual revenue of 18.67B KRW with 7.96% growth. FutureChem Co.,Ltd had revenue of 6.16B in the quarter ending December 31, 2025, a decrease of -1.24%.
Revenue
18.67B
Revenue Growth
+7.96%
P/S Ratio
25.34
Revenue / Employee
n/a
Employees
n/a
Market Cap
473.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 18.67B | 1.38B | 7.96% |
| Dec 31, 2024 | 17.29B | 3.33B | 23.81% |
| Dec 31, 2023 | 13.97B | 1.39B | 11.09% |
| Dec 31, 2022 | 12.57B | 755.26M | 6.39% |
| Dec 31, 2021 | 11.82B | 805.07M | 7.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dong-A Socio Holdings | 1.40T |
| JW Holdings | 935.51B |
| JW Pharmaceutical | 775.30B |
| Dong-A ST | 770.63B |
| Huons | 602.21B |
| Shinpoong Pharmaceutical Co.,Ltd | 231.90B |
| Bukwang Pharmaceutical | 184.38B |
| Korea United Pharm | 161.44B |